Market News How it works Learn FAQ
| RCT 0.0827 8.67% | NU 12.59 -16.95% | EWZ 34.15 -19.82% | BBD 2.93 -28.01% | TGL 0.2427 9.57% | AZTR 1.53 113.99% | ITUB 7.7 -20.37% | XP 15.705 -48.36% | NVD 3.99 -4.77% | SRTM 0.3 -30.28% | WFF 0.0898 12.25% | SPCX 146.9 -0.40% | PBR 22.5 -13.99% | SHFS 0.094 -29.00% | SOXL 90.5 8.31% | INTC 90.47 4.04% | VALE 12 -3.23% | NVDA 216 2.39% | CLRO 4.97 52.92% | NOK 8.64 6.14% | JBLU 2.37 -9.71% | TSLL 10.76 10.25% | CRWV 55.19 1.76% | GCDT 0.1545 -12.27% | SOXS 47.98 -8.54% | RIG 6.53 1.87% | NWGL 0.0869 5.98% | ABEV 2.83 -14.24% | RWM 14.5 -0.34% | BITO 10.65 -1.66% | AAL 12.2 0.74% | GPUS 0.1785 5.68% | TSLG 5.38 10.47% | T 20.85 -0.38% | SGRY 23.25 47.62% | IREN 25.43 2.11% | INTR 4.68 -34.91% | SBS 4.73 -26.09% | NFLX 63.9 -2.96% | GRAB 2.71 -2.87% | TSLA 391.62 5.21% | QID 14.22 -2.27% | WULF 11.98 5.83% | TQQQ 68.43 3.23% | CIFR 7.71 -2.90% | RBNE 0.17 -10.53% | SID 0.9118 -22.73% | SPDN 8.5 -0.47% | VZ 43.1 -3.49% | LUCD 0.5007 21.82%
NVInvitae Corporation logo

Invitae Corporation (NVTA)

New York Stock Exchange · Currency in USD
$0.02 ▼ -0.01 (-35.59%)
At close: Feb 14, 3:59 PM ET. Market closed.

Summary

Previous Close
$0.03
Open
$0.02
Day's Range
$0.02 – $0.02
52 Week Range
$0.02 – $2.34
Volume
22,459,258
Avg. Volume
12,849,005
Market Cap
$5.44M
Beta (5Y Monthly)
1.59
PE Ratio (TTM)
--
EPS (TTM)
-$13.18
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$9.75

Profile: Invitae Corporation

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Full-time employees
1,700
CEO
Kenneth D. Knight

Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators.

Earnings

DateEst.Actual
Feb 27, 2024-$0.30-$0.34Miss
Nov 8, 2023-$0.30-$0.10Beat
Aug 8, 2023-$0.37-$0.30Beat
May 9, 2023-$0.41-$0.37Beat
Feb 28, 2023-$0.55-$0.34Beat
Nov 8, 2022-$0.59-$0.42Beat

Analyst view

Consensus price target
$9.75 ▲ +51,215.8%
Range $2.25 – $17.00
Rating: Hold
Buy 27% · Hold 40% · Sell 33%

Get free alerts on NVTA and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.